Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato, MBA
CEOJoaquin Duato, MBA
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
626.84B
Market cap626.84B
Price-Earnings ratio
30.23
Price-Earnings ratio30.23
Dividend yield
2.01%
Dividend yield2.01%
Average volume
6.48M
Average volume6.48M
High today
$261.71
High today$261.71
Low today
$259.16
Low today$259.16
Open price
$260.80
Open price$260.80
Volume
3.92M
Volume3.92M
52 Week high
$274.90
52 Week high$274.90
52 Week low
$173.33
52 Week low$173.33

Stock Snapshot

The current Johnson & Johnson(JNJ) stock price is $260.35, with a market capitalization of 626.84B. The stock trades at a price-to-earnings (P/E) ratio of 30.23 and offers a dividend yield of 2.01%.

On 2026-08-15, Johnson & Johnson(JNJ) stock moved within a range of $259.16 to $261.71. With shares now at $260.35, the stock is trading +0.5% above its intraday low and -0.5% below the session's peak.

Trading volume for Johnson & Johnson(JNJ) stock has reached 3.92M, versus its average volume of 6.48M.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $274.90 and a low of $173.33.

Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $274.90 and a low of $173.33.

JNJ News

TipRanks 6h
Intel, Netflix, Pfizer, Coca-Cola, J&J Insider Shock

Insiders have been trading these 5 stocks: ((INTC)), ((NFLX)), ((PFE)), ((KO)) and ((JNJ)). Here is a breakdown of their recent trades and their value. Unlock...

TipRanks 17h
Top Johnson & Johnson Insider Makes a High-Profile Move With Massive Stock Sale

New insider activity at Johnson & Johnson ( (JNJ) ) has taken place on August 14, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Pre...

BBC 1d
European Athletics Championships 2026: Katarina Johnson-Thompson boosts heptathlon medal hopes in high jump - BBC

...

European Athletics Championships 2026: Katarina Johnson-Thompson boosts heptathlon medal hopes in high jump - BBC

Analyst ratings

73%

of 26 ratings
Buy
73.1%
Hold
23.1%
Sell
3.8%

More JNJ News

Nasdaq 1d
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?

Key Points Fidelity MSCI Health Care Index ETF offers a lower expense ratio of 0.08% compared to the 0.37% fee for iShares U.S. Pharmaceuticals ETF. iShares'...

Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?
Simply Wall St 2d
What Johnson & Johnson's Leadership Shift and Cancer Drug Priority Review Mean For Shareholders

Johnson & Johnson recently announced that longtime Innovative Medicine leader Jennifer Taubert has retired after more than 21 years with the company, while Tom...

What Johnson & Johnson's Leadership Shift and Cancer Drug Priority Review Mean For Shareholders
The Motley Fool 2d
Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested Pays Annually.

If you're not aware of them, there's a group of stocks known as Dividend Kings. This select group of companies have all increased their dividends annually for a...

Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested Pays Annually.
Simply Wall St 2d
Intuitive Surgical Is Facing Fresh Competition In U.S. Surgical Robotics

Intuitive Surgical (NasdaqGS: ISRG) faces new U.S. competition after Johnson & Johnson received FDA authorization for its Ottava robotic surgical system. Ottav...

Intuitive Surgical Is Facing Fresh Competition In U.S. Surgical Robotics
24/7 Wall St. 3d
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield

want a stake in closing that gap. See the offering → (sponsor) Goldman Sachs projects AI demand will exceed compute center capacity for years to come. One Sky...

Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield
24/7 Wall St. 3d
The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is

The Energy and Pharma Giants Quietly Funding HDV’s 3% Yield, and How Safe Each One Is By David Beren Published Aug 12, 12:12PM EDT Quick Read XOM and JNJ earn...

The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is
Simply Wall St 3d
Johnson & Johnson Advances Seltorexant In Major Depressive Disorder

Johnson & Johnson (NYSE: JNJ) reports progress in its R&D pipeline, including clinical development of seltorexant for major depressive disorder. The company ad...

Johnson & Johnson Advances Seltorexant In Major Depressive Disorder

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.